Orotate phosphoribosyltransferase levels measured by a newly established enzyme-linked immunosorbent assay in gastric carcinoma

Cancer Science

Volumn 97, Issue 6, 2006, Pages 492-498

  Sakurai, Yoichi ^a   Sakamoto, Kazuki ^b   Sugimoto, Yoshikazu ^b   Yoshida, Ikuo ^a   Masui, Toshihiko ^a   Tonomura, Shuhei ^a   Inaba, Kazuki ^a   Shoji, Mitsutaka ^a   Nakamura, Yasuko ^a   Uyama, Ichiro ^a   Komori, Yoshiyuki ^a   Ochiai, Masahiro ^a   Matsuura, Shiro ^c   Tanaka, Hideyuki ^c   Oka, Toshinori ^b   Fukushima, Masakazu ^b  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b R D Hq Tokushima Res Ctr T   (Japan)

^c MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; OROTATE PHOSPHORIBOSYLTRANSFERASE; POLYCLONAL ANTIBODY; UFT;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MAXIMUM TOLERATED DOSE; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STOMACH CARCINOMA; TUMOR XENOGRAFT; VALIDATION STUDY;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; DRUG RESISTANCE, NEOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUOROURACIL; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; OROTATE PHOSPHORIBOSYLTRANSFERASE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 33744546078     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2006.00200.x     Document Type: Article

References (22)

1. Macdonald JS, Gohmann JJ. Chemotherapy of advanced gastric cancer: present status, future prospects. Semin Oncol 1988; 15: 42-9.
2. Shirasaka T, Nakano K, Takechi T et al. Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats. Cancer Res 1996; 56: 2602-266.
3. Etienne MC, Cheradame S, Fischel JL et al. Response to fluorouracil therapy in cancer patients: The role of tumoral dihydropyrimidine dehydrogenase activity. J Clin Oncol 1995; 13: 1663-70.
4. Johnston PG, Lenz HJ, Leichman CG et al. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 1995; 55: 1407-12.
5. Schoffski P. The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors. Anticancer Drugs 2004; 15: 85-106.
6. Fukushima M, Murakami Y, Suzuki K. The analysis of the innate pathways of 5-fluorouracil phosphorylation in human gastrointestinal cancer cell lines in vitro and in vivo. Oncol Rep 1997; 4: 1189-94.
7. Sakamoto K, Sugimoto Y, Miyadera K, Oka T, Fukushima M. Preparation of anti-OPRT antibody for immunochemical detection. Jpn J Cancer Chemother 2005; 32: 653-8.
8. Shirasaka T, Shimamoto Y, Fukushima M. Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats. Cancer Res 1993; 53: 4004-9.
9. Kurebayashi J, Yamamoto Y, Udagawa K, Okubo S, Fukushima M, Sonoo H. Establishment of enzyme-linked immunosorbent assays for thymidylate synthase and dihydropyriminide dehydrogenase in cancer tissues. Oncol Rep 2004; 11: 973-9.
10. Peters GJ, van Groeningen CJ, Laurensse EJ, Pinedo HM. A comparison of 5-fluorouracil metabolism in human colorectal cancer and colon mucosa. Cancer 1991; 68: 1903-199.
11. Suttle DP, Bugg BY, Winkler JK, Kanalas JJ. Molecular cloning and nucleotide sequence for the complete coding region of human UMP synthase. Proc Natl Acad Sci USA 1988; 85: 1754-8.
12. Inaba M, Sawada H, Sadata A, Hamada H. Circumvention of 5-fluorouracil resistance in human stomach cancer cells by uracil phosphoribosyltransferase gene transduction. Jpn J Cancer Res 1999; 90: 349-54.
13. Fujii R, Seshimo A, Kameoka S. Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma. Int J Clin Oncol 2003; 8:72-8.
14. Isshi K, Sakuyama T, General T et al. Predicting 5-FU sensitivity using human colorectal cancer specimens: Comparison of tumor dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activities with in vitro chemosensitivity to 5-FU. Int J Clin Oncol 2002; 7: 335-42.
15. Katsumata K, Tomioka H, Sumi T et al. Correlation between clinicopathologic factors and kinetics of metabolic enzymes for 5-fluorouracil given to patients with colon carcinoma by two different dosage regimens. Cancer Chemother Pharmacol 2003; 51: 155-60.
16. Ishikawa Y, Kubota T, Otani Y et al. Dihydropyrimidine dehydrogenase and messenger RNA levels in gastric cancer: Possible predictor for sensitivity to 5-fluorouracil. Jpn J Cancer Res 2000; 91: 105-12.
17. Yoshida I, Sakurai Y, Komori Y et al. Successful downstaging by S-1-based chemotherapy followed by surgical resections for gastric carcinoma with extensive distant lymph node metastasis - report of two cases and a review of cases with surgical resection after downstaging by S-1-based chemotherapy. Hepatogastroenterology 2005; 52: 978-84.
18. Kamoshida S, Shiogama K, Shimomura R et al. Immunohistochemical demonstration of fluoropyrimidine-metabolizing enzymes in various types of cancer. Oncol Rep 2005; 14: 1223-30.
19. Kamoshida S, Sakamoto N, Matsuoka H et al. Heat-assisted stretching of paraffin sections on hot plate weakens immunoreactivity of orotate phosphoribosyltransferase. Acta Histochem Cytochem 2005; 38: 69-74.
20. Ichikawa W, Uetake H, Shirota Y et al. Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer. Br J Cancer 2003; 89: 1486-92.
21. Evrard A, Cuq P, Robert B, Vian L, Pelegrin A, Cano JP. Enhancement of 5-fluorouracil cytotoxicity by human thymidine-phosphorylase expression in cancer cells: In vitro and in vivo study. Int J Cancer 1999; 80: 465-70.
22. Salonga D, Danenberg KD, Johnson M et al. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res 2000; 6: 1322-7.